Form 8-K - Current report:
SEC Accession No. 0001390478-15-000043
Filing Date
2015-10-30
Accepted
2015-10-30 09:16:02
Documents
3
Period of Report
2015-10-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gale-201510308xk.htm 8-K 45628
2 EXHIBIT 99.1 gale-20151030ex991.htm EX-99.1 16176
3 GRAPHIC exhibit991pressreleas_image1.jpg GRAPHIC 102112
  Complete submission text file 0001390478-15-000043.txt   203984
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 151185590
SIC: 2834 Pharmaceutical Preparations